Fixture Display LLC
12 extracted findings · 2 model-assigned issue types
FDA source excerpt, selected passage
The 3-ply Surgical Mask Disposable Face Mask (which your website represents is manufactured by Dongguan Weier Medical and Technology Co., Ltd.) is offered for sale in the United States without marketing approval, clearance, or authorization from the FDA.
FDA published a close-out letter on Oct 4, 2021. The findings below are from the original warning letter.
Findings and supporting evidence
Model-assisted readings, not an exhaustive interpretation. Compare with the extracted source findings below.
The 3-ply surgical mask was sold without FDA marketing approval, clearance, or authorization.
Supporting FDA text
Source excerpt · automated text-match checkThe 3-ply Surgical Mask Disposable Face Mask (which your website represents is manufactured by Dongguan Weier Medical and Technology Co., Ltd.) is offered for sale in the United States without marketing approval, clearance, or authorization from the FDA.
The surgical mask lacked an approved PMA or IDE, making it adulterated.
Supporting FDA text
Source excerpt · automated text-match checkAccordingly, this product is adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because your firm does not have an approved application for premarket approval (PMA) in effect pursuant to section 515(a) of the Act, 21 U.S.C. § 360e(a), or an approved application for an investigational device exemption (IDE) under section 520(g) of the Act, 21 U.S.C. § 360j(g).
The firm failed to submit a 510(k) notice before introducing the surgical mask.
Supporting FDA text
Source excerpt · automated text-match checkThis product is also misbranded under section 502(o) of the Act, 21 U.S.C. § 352(o), because your firm did not notify the agency of its intent to introduce the devices into commercial distribution, as required by section 510(k) of the Act, 21 U.S.C. § 360(k).
Both masks were misbranded because their labeling was false or misleading.
Supporting FDA text
Source excerpt · automated text-match checkIn addition, the KN95 Face Mask*1* and the 3-Ply Surgical Mask Disposable Face Mask are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because their labeling is false or misleading.
The website displayed a misleading FDA registration certificate for the KN95 mask.
Supporting FDA text
Source excerpt · automated text-match checkDisplaying a “Certification of FDA Registration” issued by “UCL-REGSERVICE INC” (UCL-REGSERVICE Certificate) alongside KN95 Face Mask product information.
The website displayed a misleading FDA registration certificate for the surgical mask.
Supporting FDA text
Source excerpt · automated text-match checkDisplaying a “Certification of FDA Registration” issued by “Shenzhen CCT Testing Technology Co” (Shenzhen Certificate) alongside the 3-ply Surgical Mask Disposable Face Mask product information.
The website falsely claimed the surgical mask was FDA approved.
Supporting FDA text
Source excerpt · automated text-match checkStatement alongside the 3-Ply Surgical Mask Disposable Face Mask that the product is “FDA Approved”
The website falsely claimed the KN95 masks meet all FDA requirements for medical use.
Supporting FDA text
Source excerpt · automated text-match checkStatement that the KN95 Face Masks “are genuinly [sic] KN95 which meets all FDA requirements for medical and trade use”
The FDA logo on the certificate misleadingly implied FDA approval of the KN95 mask.
Supporting FDA text
Source excerpt · automated text-match checkThe UCL-REGSERVICE Certificate bearing the FDA logo, positioned near images of and information about the KN95 Face Mask is misleading because it implies FDA approval, clearance, authorization, certification, endorsement, or other evaluation of the product and/or establishment
FDA has not approved the surgical mask, making contrary statements false.
Supporting FDA text
Source excerpt · automated text-match checkIn addition, FDA has not approved the 3-Ply Surgical Mask Disposable Face Mask, so statements to the contrary are false.
The FDA logo on the certificate misleadingly implied FDA approval of the surgical mask.
Supporting FDA text
Source excerpt · automated text-match checkFurthermore, display of the Shenzhen Certificate bearing the FDA logo positioned near images of and information about the 3-ply Surgical Mask Disposable Face Mask is misleading because it implies FDA approval, clearance, authorization, certification, endorsement, or other evaluation of the product(s) and/or establishment
Disclaimers on the certificates were too small and placed to mitigate the misleading impression.
Supporting FDA text
Source excerpt · automated text-match checkAlthough the KN95 Face Mask and 3-ply Surgical Mask Disposable Face Mask Certificates contain legible language that appears to be intended to function as a disclaimer, including a statement that the Certificates do not denote FDA endorsement or approval, statements that FDA does not issue or recognize certificates of registration, and a statement that quotes 21 CFR 807.39, the small font size and overall placement of such language could be easily overlooked and does not limit or otherwise mitigate the misleading impression created by the use of the Certificates.
Findings extracted from the letter
Selected FDA passages, not the complete letter.
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
Source passage selected by the model
What FDA requested
Model-assisted summary. Consult the letter for complete requests and conditions.
- Notify FDA in writing within 15 business days of steps taken to address violations
- Explain how the firm plans to prevent these or similar violations from recurring
- Include documentation of any actions taken and a timetable for planned actions
- Provide reasoning and supporting information if the firm believes products are not in violation
Sections and clauses cited
As cited in this historical letter, not a statement of current regulatory requirements.